Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
Résumé
[No abstract available]
Mots clés
Child
Core Binding Factor Alpha 2 Subunit
Humans
Leukemia, Myeloid, Acute
Mutation
Prognosis
transcription factor RUNX1
RUNX1 protein, human
acute myeloid leukemia
adolescent
Article
cancer mortality
cancer prognosis
child
controlled study
cytogenetics
cytology
event free survival
female
frameshift mutation
France
gene deletion
gene frequency
gene mutation
human
leukemia remission
major clinical study
male
missense mutation
nonsense mutation
overall survival
pediatric patient
risk assessment
risk factor
RUNX1 gene
genetics
mutation
prognosis
Domaines
Cancer
Origine : Fichiers éditeurs autorisés sur une archive ouverte